Olav Bergheim - Chairman and Managing Director, Fjord Ventures

Mr. Bergheim has more than 30 years of experience in creating and managing life science companies including Chimeric Therapies, Inc., VenPro, 3F Therapeutics, Orqis Medical, Volcano Therapeutics, Symphony Medical, Inc, Glaukos Corporation, Windy Hill Medical, and Dentatek Corporation. Prior to starting Fjord Ventures, Mr. Bergheim was general partner of Domain Associates. Mr. Bergheim's vast experience also includes nearly 20 years of general management positions at Baxter Healthcare, including as president of the $700-million Cardiovascular Group, as well as positions as president of Immunotherapy Worldwide, president of BioTech Europe, and president of Baxter Germany. Mr. Bergheim earned his BS and MS in pharmacy at the University of Oslo. He also completed the Executive Program at the University of Virginia’s Darden School of Business Administration.

Erik Amble - Managing Partner, NeoMed Management

Mr. Amble has extensive venture capital investing experience, the last 15 years in the healthcare and life science industry. He is currently managing partner at NeoMed, an international venture capital company he founded. Mr. Amble previously co-founded and was chairman of the Norwegian Venture Capital Association. He has been chairman of Genovision AS and Alertis Medical AS, and a board member of Clavis Pharma and Thommen Medical AG. Mr. Amble is currently chairman of NovaShunt AG and serves on the board of Windy Hill Medical Inc. Mr. Amble holds a doctoral degree in organic chemistry from the University of Oslo and a Master of Science degree in Management from the Graduate School of Business, Stanford University.

Michael Perry - Chief Technical Officer, Minnow Medical

For more than two decades, Mr. Perry's leadership experience has been pivotal in successfully developing products and accelerating marketplace entry. Prior to joining Minnow Medical, Mr. Perry, a holder of 20 patents, was the co-founder and executive vice president at Pacific Consultants. A leader in the design and analysis of a variety of medical devices including vascular stents, Pacific Consultants was ranked #134 on Inc.'s list of fastest growing private companies. At the FDA's request, he has lectured industry executives on the importance of product design and regulatory requirements. Mr. Perry graduated from San Jose State University with a BS degree in mechanical engineering.